Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 714 in moderate to severe psoriasis
NCT00443326Phase 2Completed
- Sponsor
- Amgen
- Start
- Mar 2007
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of ordesekimab in psoriasis, sponsored by Amgen. Started Mar 2007; status: completed.
02
Drugs
ordesekimab
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00443326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443326.